{
    "clinical_study": {
        "@rank": "114126", 
        "arm_group": [
            {
                "arm_group_label": "Diphenhydramine(Benadryl)", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "Lidocaine", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Pain as a result of nerve injury (neuropathic pain) is a particularly severe form of chronic\n      pain. Common examples of neuropathic pain are pain due to diabetes and shingles. There is\n      good evidence that an intravenous infusion of lidocaine (local anesthetic) is useful for the\n      management of neuropathic pain in the short term - up to six hours."
        }, 
        "brief_title": "The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Neuropathic Pain", 
        "condition_browse": {
            "mesh_term": "Neuralgia"
        }, 
        "detailed_description": {
            "textblock": "This study will examine the role of intravenous lidocaine in the relief of neuropathic pain\n      over four weeks following infusion compared to a salt water infusion.  If we can show that\n      intravenous lidocaine provides sustained benefit for up to one month, this will be a major\n      advance in the management of individuals suffering from neuropathic pain."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Chronic neuropathic pain of peripheral nerve origin as determined by the    study\n             physician and a score of 4/10 or greater on the DN4 questionnaire.\n\n          -  Moderate to severe pain as defined by screening average pain intensity of 5 or\n             greater on a 0-10 numerical rating scale.\n\n          -  Neuropathic pain duration of at least 6 months.\n\n        Exclusion Criteria:\n\n          -  Presence of clinically significant cardiac disease.\n\n          -  Poorly controlled seizure disorder.\n\n          -  Significant psychiatric disorder.\n\n          -  History of allergy to lidocaine or any other amide local anesthetic\n\n          -  History of allergy to diphenhydramine.\n\n          -  Prior treatment with a local anesthetic infusion.\n\n          -  Neuropathic pain due to cancer or complex regional pain syndrome\n\n          -  Language barrier or cognitive impairment that would preclude understanding  of the\n             study and filling out of questionnaires\n\n          -  Lack of a driver to transport the patient to and from the pain clinic."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "32", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 22, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01669967", 
            "org_study_id": "R11-132", 
            "secondary_id": "17806"
        }, 
        "intervention": [
            {
                "arm_group_label": "Lidocaine", 
                "description": "Lidocaine 5 mg/kg in 250 ml of normal saline infused over 45 minutes.", 
                "intervention_name": "Lidocaine", 
                "intervention_type": "Drug", 
                "other_name": "Xylocaine"
            }, 
            {
                "arm_group_label": "Diphenhydramine(Benadryl)", 
                "description": "Diphenhydramine 50 mg in 250 ml of normal saline infused over 45 minutes.", 
                "intervention_name": "Diphenhydramine", 
                "intervention_type": "Drug", 
                "other_name": "Benadryl"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Diphenhydramine", 
                "Promethazine", 
                "Lidocaine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 20, 2012", 
        "location": {
            "contact": {
                "last_name": "Cathy Rohfritsch, RN", 
                "phone": "519-646-6019"
            }, 
            "facility": {
                "address": {
                    "city": "London", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "N6A 4V2"
                }, 
                "name": "St. Joseph's Health Care"
            }, 
            "investigator": {
                "last_name": "Dwight Moulin, Dr.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin", 
        "overall_official": {
            "affiliation": "University of Western Ontario, Canada", 
            "last_name": "Dwight Moulin, Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Canada: Health Canada", 
                "Canada: Canadian Institutes of Health Research"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Changes from Baseline Pain scores on the Visual Analog Scale at 6 weeks", 
            "safety_issue": "No", 
            "time_frame": "every 24 hours  for six weeks post-infusion"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01669967"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Lawson Health Research Institute", 
            "investigator_full_name": "Dwight Moulin", 
            "investigator_title": "Dr. D. Moulin Professor, Departments of Clinical Neurological Sciences and Oncology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Hospital Anxiety and Depression Scale", 
                "safety_issue": "No", 
                "time_frame": "obtained baseline, 24 and 72 hours and then weeks 1,2,3, and 4"
            }, 
            {
                "measure": "Modified Brief Pain Inventory", 
                "safety_issue": "No", 
                "time_frame": "obtained baseline, 24, 72 hours and then weeks 1,2,3 and 4"
            }, 
            {
                "measure": "Leeds Sleep Evaluation Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "obtained baseline, 24, 72 hours and then weeks 1,2,3 and 4"
            }, 
            {
                "measure": "Patient Global Satisfaction with Treatment and Impression of Change", 
                "safety_issue": "No", 
                "time_frame": "obtained baseline, 24, 72 hours and then weeks 1,2,3 and 4"
            }, 
            {
                "measure": "Side Effects", 
                "safety_issue": "No", 
                "time_frame": "obtained baseline, 24, 72 hours and then weeks 1,2,3 and 4"
            }, 
            {
                "measure": "Quality of Life Health Outcome Instrument", 
                "safety_issue": "No", 
                "time_frame": "obtained baseline, 24, 72 hours and then weeks 1,2,3 and 4"
            }
        ], 
        "source": "Lawson Health Research Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Lawson Health Research Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}